ZyDoc Extends Clinical Data Center For Pharmaceutical Research
ZyDoc, an award-winning technology leader in e-Transcription and Automated Medical Documentation Solutions, announced that it will be offering a customizable suite of clinical data solutions, MedDocTM designed to fulfill the needs of the pharmaceutical industry. The solutions will be used for clinical and marketing research, FDA studies, and post-approval drug monitoring. Currently, these systems are used by physicians for transcription and extended value of EMR (electronic medical records) and PAC systems by allowing the doctors to expedite data capture into the systems with dictation.
Hauppauge, New York (PRWEB) August 10, 2005 -- ZyDoc, an award-winning
technology leader in e-Transcription and Automated Medical Documentation
Solutions, announced that it will be offering a customizable suite of clinical
data solutions, MedDocTM designed to fulfill the needs of the pharmaceutical
industry. The solutions will be used for clinical and marketing research, FDA
studies, and post-approval drug monitoring. Currently, these systems are used by
physicians for transcription and extended value of EMR (electronic medical
records) and PAC systems by allowing the doctors to expedite data capture into
the systems with dictation.
James Maisel, M.D., Chairman of ZyDoc
explains, "ZyDoc is delighted to offer our distinctive technology to the
pharmaceutical industry. The companies innovative solutions allow a
pharmaceutical company to effortlessly initiate an FDA study with web-based
training with documentation, distribution of protocols, consents, and updates to
an unlimited numbers of physicians from a centralized point. This remarkable
solution is also well suited for physicians and eliminates their travel
requirements for education and training. ZyDoc serves as the third-party
administrator for the clinical studies, handling HIPAA requirements, and
Business Associates Agreements with physicians and patients.
ZyDoc has
over 10 years of experience in working with physicians who want to document
their medical encounters quickly and efficiently. ZyDoc offers low risk, high
productivity solutions focused on dictation for data capture involving no change
in work habits, infrastructure cost, outlays or extensive training. The company
converts the dictations into web-based forms and enters the information into a
relational database allowing searches on any data combinations. This provides an
effective means for post approval monitoring of drug use and complications. The
web-based TrackDoc system offers substantial advantages to physicians and
investigator over traditional alternatives and can be implemented in days. These
solutions are suitable for 100% of physicians and require no IT experience or
internal support. ZyDoc solutions seem like a transcription service on the front
end to the physicians and have all the advantages of traditional formal clinical
investigational studies. All data is easily shared with other providers or
investigators and will ultimately result in larger studies, implemented faster
with lower costs."
According to Steve Koski, CEO and president of ZyDoc,
"The ZyDoc technology platform offers a number of advantages to pharmaceutical
companies over traditional FDA studies in terms of the ease of implementation,
operations, total costs, quality, speed of care, and disaster recovery. The
solutions require no software or IT personnel, and are compatible with all PCs
and operating systems with Internet browser capability. There is no training
involved or complicated software to customize or learn. Doctors can start
dictating data immediately after enrollment using 800 toll free dialup or
digital handheld recorder. Documents are always available on the Internet with
HIPAA secure connections, and can be reviewed and signed remotely. The documents
can also be automatically downloaded and printed to a PC, electronically signed,
faxed, or shared with authorized caregivers over the Internet. Data can also be
stripped of PHI (personal health information) and caregivers for HIPAA and
ethical requirements. The ZyDoc carrier class data center has proven reliable
without failure over the past year and was operational even during the Northeast
blackout of 2003."
Availability
ZyDoc is offering MedDoc
immediately to pharmaceutical companies. Current ZyDoc transcription clients are
interested in enrolling in clinical investigations in all specialties.
Investigators can contact the ZyDoc data center at 631-273-6125. Doctors can
start data collection immediately with the TelDoc 800 service or use low-cost
digital handheld recorders. ZyDoc provides multimedia demonstrations, training,
and support via the Internet at http://ZyDoc.webex.com. For more information on ZyDoc Clinical
Data Solutions, visit www.ZyDoc.com.
About ZyDoc.com
Corporation.
ZyDoc is a transcription service and software development
company providing e-Transcription, automated electronic health record (EHR),
documentation, and infrastructure ASP legacy-replacement solutions. Physicians,
transcriptionists, and other healthcare professionals use these services to
produce, organize, and distribute multi-specialty patient electronic medical
records (EMR) sees in Community Health Information Networks (CHIN). ZyDoc solves
the PC literacy, data entry bottleneck, implementation, and cost issues that
plague other clinical documentation and transcription companies. The company
uses transparent embedded technology that leverages front and back-end speech
recognition, workflow enhancements, and the Internet. ZyDoc is a development
partner with SUNY Computer Sciences at Stony Brook, Microsoft Solutions Partner,
ScanSoft Platinum Dealer, and an IBM Speech Premier Business Partner. In 2004,
ZyDoc was ranked third nationally in medical transcription by The Medical
Records Institute. ZyDoc has won other awards and was named The Healthcare
Tablet Application of 2003.
Press contacts:
James M. Maisel,
M.D.
Chairman, ZyDoc.com
1455 Veterans Memorial Highway
Hauppauge, NY
11749
www.ZyDoc.com
jmaisel @ zydoc.com
631-273-1963
SOURCE: ZyDoc
# # #
Source : http://www.prweb.com/releases/2005/8/prweb270814.htm